BRA
Bender Robert & Associates Portfolio holdings
AUM
$448M
This Quarter Return
+17.22%
1 Year Return
+20.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$397M
AUM Growth
+$397M
(+16%)
Cap. Flow
-$1.78M
Cap. Flow
% of AUM
-0.45%
Top 10 Holdings %
Top 10 Hldgs %
71.23%
Holding
50
New
2
Increased
12
Reduced
27
Closed
–
Top Buys
| 1 |
Palo Alto Networks
PANW
|
$286K |
| 2 |
Target
TGT
|
$207K |
| 3 |
Duke Energy
DUK
|
$202K |
| 4 |
ServiceNow
NOW
|
$147K |
| 5 |
Ulta Beauty
ULTA
|
$138K |
Top Sells
| 1 |
Apple
AAPL
|
$860K |
| 2 |
AbbVie
ABBV
|
$578K |
| 3 |
Gilead Sciences
GILD
|
$426K |
| 4 |
AstraZeneca
AZN
|
$366K |
| 5 |
Illumina
ILMN
|
$148K |
Sector Composition
| 1 | Technology | 42.33% |
| 2 | Consumer Discretionary | 28.14% |
| 3 | Healthcare | 17.65% |
| 4 | Communication Services | 10.14% |
| 5 | Utilities | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AstraZeneca
AZN
$248B
| $1.56M | 0.39% |
23,178
-5,441
| -19% | -$366K |
|
27
Bristol-Myers Squibb
BMY
$96.4B
| $1.42M | 0.36% |
27,692
-5
| -0% | -$257 |
|
|
28
AbbVie
ABBV
$374B
| $1.42M | 0.36% |
9,157
-3,727
| -29% | -$578K |
|
29
Costco
COST
$416B
| $1.12M | 0.28% |
1,697
-34
| -2% | -$22.4K |
|
30
Abbott
ABT
$228B
| $785K | 0.2% |
7,134
-182
| -2% | -$20K |
|
31
Merck
MRK
$212B
| $733K | 0.18% |
6,723
-243
| -3% | -$26.5K |
|
32
Johnson & Johnson
JNJ
$429B
| $721K | 0.18% |
4,601
-100
| -2% | -$15.7K |
|
33
Boeing
BA
$180B
| $683K | 0.17% |
2,619
-40
| -2% | -$10.4K |
|
34
Paychex
PAYX
$49B
| $644K | 0.16% |
5,405
| – | – |
|
35
JPMorgan Chase
JPM
$822B
| $600K | 0.15% |
3,526
-40
| -1% | -$6.8K |
|
36
Nucor
NUE
$33.6B
| $559K | 0.14% |
3,210
-10
| -0.3% | -$1.74K |
|
37
Deere & Co
DE
$128B
| $532K | 0.13% |
1,330
-10
| -0.7% | -$4K |
|
38
UroGen Pharma
URGN
$890M
| $521K | 0.13% |
34,701
| – | – |
|
39
Caterpillar
CAT
$194B
| $418K | 0.11% |
1,414
-8
| -0.6% | -$2.37K |
|
40
BioCryst Pharmaceuticals
BCRX
$1.76B
| $339K | 0.09% |
56,600
| – | – |
|
41
Visa
V
$678B
| $271K | 0.07% |
1,042
-78
| -7% | -$20.3K |
|
42
Evolus
EOLS
$486M
| $264K | 0.07% |
25,070
| – | – |
|
43
Oracle
ORCL
$629B
| $252K | 0.06% |
2,389
| – | – |
|
44
Idexx Laboratories
IDXX
$51.2B
| $234K | 0.06% |
422
-38
| -8% | -$21.1K |
|
45
Pfizer
PFE
$141B
| $223K | 0.06% |
7,755
-555
| -7% | -$16K |
|
|
46
Target
TGT
$41.9B
| $207K | 0.05% |
+1,450
| New | +$207K |
|
|
47
Duke Energy
DUK
$94.7B
| $202K | 0.05% |
+2,080
| New | +$202K |
|
48
Pulse Biosciences
PLSE
$1.03B
| $126K | 0.03% |
10,325
| – | – |
|
49
Summit Therapeutics
SMMT
$17.6B
| $62.8K | 0.02% |
24,059
| – | – |
|
|
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
| $10.2K | ﹤0.01% |
10,609
| – | – |
|